programmed cell death 10
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La PDCD10 gene (also known as CCM3) provides instructions for making a protein that appears to play a role in the structure of blood vessels. While the exact function of the PDCD10 protein is unclear, studies suggest that it works with other proteins to help strengthen the interactions between cells and limit leakage from blood vessels. This protein is also thought to be involved in pathways that signal cells to self-destruct (undergo apoptosis) when they have completed a certain number of cell divisions or accumulated errors in their DNA.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La PDCD10 gene (also known as CCM3) provides instructions for making a protein that appears to play a role in the structure of blood vessels. While the exact function of the PDCD10 protein is unclear, studies suggest that it works with other proteins to help strengthen the interactions between cells and limit leakage from blood vessels. This protein is also thought to be involved in pathways that signal cells to self-destruct (undergo apoptosis) when they have completed a certain number of cell divisions or accumulated errors in their DNA.
Conditions referring to this gene or chromosome
Other names
apoptosis-related protein 15
CCM3
cerebral cavernous malformation 3
PDC10_HUMAN
TFAR15
Related patient information and medicines

Patient information leaflet
Leucémie lymphoblastique aiguë
Leucémie lymphoblastique aiguë (ALL) is a condition where the bone marrow makes large numbers of abnormal immature lymphocytes. The immature cells are called lymphoblasts. Most children with ALL - about 7-8 in 10 cases - can be cured. The outlook (prognosis) for children has improved greatly over a period of 20 years or so. Children aged between 1.

Patient information leaflet
Décès ou lésions cérébrales dues à l'anesthésie
La risk of dying in the operating theatre under anesthésie est extremely small. For a healthy person having planned surgery, around 1 person may die for every 100,000 general anaesthetics given. The risk of developing brain damage as a result of an anaesthetic is extremely small. Brain damage is caused by the death or damage of brain cells. This.

Patient information leaflet
Cancers infantiles
Childhood cancer is rare and is much less common than cancer in adults. There are many different type of cancer that can affect children and childhood cancers can cause many different symptoms. Even if a cure is not possible, a course o... What is the outcome (prognosis). Even though cancer is very uncommon in children, it is the most common cause.

Patient information leaflet
Cancer du col de l'utérus
If the cells that make up the cervix multiply abnormally, you develop cancer du col de l'utérus (cancer of the cervix). What is cervical cancer. What is cervical cancer? | Patient Explainers If the cells that make up the cervix multiply abnormally, you develop cancer du col de l'utérus (cancer of the cervix). Cervical cancer is the fourteenth most common type of.

Patient information leaflet
Immunisation contre la grippe
This is reviewed each year. The aim is to protect people who are more likely to develop complications from flu. People in these groups can get the flu vaccine as part of the national flu programme, free of charge. For the 2025-26 flu season Anyone in the following groups can receive the flu vaccine as part of the national programme: People aged 65.

Patient information leaflet
Cancer du pénis
Cancer du pénis est a cancer that develops sur the penis. A cancerous (malignant) tumour starts from one abnormal cell. The exact reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply 'out of control'. See the separate leaflet called Causes of.
Lectures complémentaires et références
- programmed cell death 10; MedlinePlus, National Library of Medicine.
- Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E; Societe Francaise de Neurochirurgie. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005 Jan;76(1):42-51. doi: 10.1086/426952. Epub 2004 Nov 12.
- Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, Ogilvy CS, Berg MJ, Crawford SC, Scott RM, Steichen-Gersdorf E, Sabroe R, Kennedy CT, Mettler G, Beis MJ, Fryer A, Awad IA, Lifton RP. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998 Nov;7(12):1851-8. doi: 10.1093/hmg/7.12.1851.
- Guclu B, Ozturk AK, Pricola KL, Bilguvar K, Shin D, O'Roak BJ, Gunel M. Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery. 2005 Nov;57(5):1008-13. doi: 10.1227/01.neu.0000180811.56157.e1.
- Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, Cannella M, Maglione V, Ptacek L, Johnson EW, Marchuk DA. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat. 2006 Jan;27(1):118. doi: 10.1002/humu.9389.
- Plummer NW, Zawistowski JS, Marchuk DA. Genetics of cerebral cavernous malformations. Curr Neurol Neurosci Rep. 2005 Sep;5(5):391-6. doi: 10.1007/s11910-005-0063-7.
- Verlaan DJ, Roussel J, Laurent SB, Elger CE, Siegel AM, Rouleau GA. CCM3 mutations are uncommon in cerebral cavernous malformations. Neurology. 2005 Dec 27;65(12):1982-3. doi: 10.1212/01.wnl.0000188903.75144.49.
- Voss K, Stahl S, Schleider E, Ullrich S, Nickel J, Mueller TD, Felbor U. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics. 2007 Nov;8(4):249-56. doi: 10.1007/s10048-007-0098-9. Epub 2007 Jul 27.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

